Download the following documents for more information on the Coalition for a Competitive Pharmaceutical Market (CCPM) and its work with Congress and the Administration to improve consumer access to high quality generic drugs and restore a vigorous, competitive prescription drug market. Coalition Backgrounders CCPM Mission and Principles Legislative BackgroundersPrinciples for Biogenerics Biogenerics Backgrounder Biogenerics: Safety Biogenerics: Public Health Service Act Safety Provisions Studies and Additional Resources Potential Savings That Might Be Realized By the Medicare Program From Enactment Of Legislation Such As The Access To Life-Saving Medicine Act (H.R. 6257/S. 4016) That Establishes A New cBLA Pathway For Follow-On Biologics: A Report To Pharmaceutical Care Management Association (PCMA) Based Upon A Preliminary Assessment Of Available Data
January 2, 2007 Read a summary of this study Congressional Testimony Comments to the Senate Judiciary Committee Hearing On The Law Of Biologic Medicine
June 23, 2004 Letters to Congress
CCPM Members partner with broad group of supporters and outline seven principles for the House Energy and Commerce Committee Leadership to use as they craft biogenerics legislation
April 15, 2008 CCPM Letter to the leadership of the House Committee on Energy and Commerce regarding FDA explicit authority to approve abbreviated applications for generic biopharmaceuticals
February 12, 2008 CCPM Letter to Secretary Michael O. Leavitt commending the Administration for its recent support of granting the FDA explicit authority to approve abbreviated applications for generic biopharmaceuticals
February 12, 2008 AARP, AFL-CIO, CCPM Letter to the Congressional Leadership regarding prescription drug issues
January 5, 2007
CCPM Letter to Congressman Waxman regarding the Access to Life-Saving Medicines Act
September 29, 2006 CCPM/AARP Letter to Senators Bennett and Kohl requesting a funding increase for the Office of Generic Drugs
June 21, 2006 CCPM Letter to Senators Stabenow and Lott in support of the Lower PRICED Drug Act
February 15, 2006 Letter to Senate Majority Leader Bill Frist and Senate Minority Leader Harry Reid regarding S. 1873, the Biodefense and Pandemic Vaccine and Drug Development Act of 2005
October 19, 2005 CCPM endorsement letter to original cosponsors of the Access to Life Saving Medicine Act of 2007
February 14, 2007
|
